SHANGHAI, Dec. 7, 2025 /PRNewswire/ — CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announced that clinical data from its allogeneic BCMA-targeted CAR T-cell product candidate, CT0596, for the treatment of relapsed/refractory multiple myeloma (R/R MM) was presented in a poster at the 67th American Society of… Continue reading CARsgen Announces Data of Allogeneic BCMA CAR-T Cell Therapy CT0596 for Relapsed/Refractory Multiple Myeloma at the 2025 ASH Annual Meeting
Author: PR Newswire Online News
Median PFS Trending Beyond One Year: Leads Biolabs’ LBL-034 Showcases Breakthrough Clinical Data in Oral Presentation at the 2025 ASH Annual Meeting
NANJING, China, Dec. 7, 2025 /PRNewswire/ — From December 6 to 9, 2025, the 67th Annual Meeting of the American Society of Hematology (“ASH”) was held in Orlando, Florida, USA. Nanjing Leads Biolabs Co., Ltd. (“Leads Biolabs” or the “Company”, Stock Code: 9887.HK) delivered an oral presentation on the opening day of the conference featuring… Continue reading Median PFS Trending Beyond One Year: Leads Biolabs’ LBL-034 Showcases Breakthrough Clinical Data in Oral Presentation at the 2025 ASH Annual Meeting
IASO Bio Presents Updated Results for Equecabtagene Autoleucel in High-Risk Newly Diagnosed Multiple Myeloma Patients at 2025 ASH
SHANGHAI and NANJING, China and PLEASANTON, Calif., Dec. 7, 2025 /PRNewswire/ — IASO Biotechnology (“IASO Bio”), a commercial-stage biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of novel cell therapies and biologics for hematologic malignancies and autoimmune diseases, announced the oral presentation of updated clinical data for its independently developed, fully human BCMA-targeted… Continue reading IASO Bio Presents Updated Results for Equecabtagene Autoleucel in High-Risk Newly Diagnosed Multiple Myeloma Patients at 2025 ASH
HD Hyundai Signs MOU with Indian State Government to Establish New Shipyard
Signed an exclusive business agreement with the Tamil Nadu state government to promote the establishment of a new shipyard Tamil Nadu state assessed as the most optimal site with climate and rainfall similar to Ulsan, and is expected to have additional large-scale investments in port facilities Will also be partnering with an Indian state-owned enterprise… Continue reading HD Hyundai Signs MOU with Indian State Government to Establish New Shipyard
Hydron Energy Demonstrates Low-Cost Production of Xenon with Negative Carbon Footprint for Satellite Propulsion
NORTH VANCOUVER, BC, Dec. 7, 2025 /PRNewswire/ – Hydron Energy, a leading innovator in clean fuel and gas separation technologies, today announced the successful demonstration of carbon-negative Xenon and Krypton production from air. The initiative focused on application of Hydron’s next generation metal-organic framework (MOF) in the company’s INTRUPTor™ gas separation platform for direct air… Continue reading Hydron Energy Demonstrates Low-Cost Production of Xenon with Negative Carbon Footprint for Satellite Propulsion
ASH 2025 Oral Presentation: Innovent Biologics Announces Initial Results of the First-in-Human Phase 1 Study of Trispecific Antibody IBI3003 in Relapsed or Refractory Multiple Myeloma
SAN FRANCISCO and SUZHOU, China, Dec. 7, 2025 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology and other major disease areas, announced the initial data of the first-in-human trial of IBI3003, a novel trispecific… Continue reading ASH 2025 Oral Presentation: Innovent Biologics Announces Initial Results of the First-in-Human Phase 1 Study of Trispecific Antibody IBI3003 in Relapsed or Refractory Multiple Myeloma
Investment of Approx. USD 460,000 for the Development of a Prototype Mpox Detection Test with NIPRO, TBA, Japan Institute for Health Security and others
TOKYO, Dec. 7, 2025 /PRNewswire/ — The Global Health Innovative Technology (GHIT) Fund announced today an investment of approximately JPY 70 million (USD 460,0001) for the development of a prototype detection test for mpox (formerly known as monkeypox2). Mpox is a viral infectious disease that has been spreading in the Democratic Republic of the Congo (DRC) and… Continue reading Investment of Approx. USD 460,000 for the Development of a Prototype Mpox Detection Test with NIPRO, TBA, Japan Institute for Health Security and others
Global Times: Mogao Caves’ mural paintings meet modern technology
BEIJING, Dec. 7, 2025 /PRNewswire/ — The flying Apsaras dance across the heavens; caravan bells echo along ancient routes. Dunhuang, a pivotal hub on the ancient Silk Road, served as a crossroads where diverse civilizations converged, giving birth to the radiant splendor of the Mogao Caves. As a world-renowned treasure house of art and cultural… Continue reading Global Times: Mogao Caves’ mural paintings meet modern technology
The 4th China International Supply Chain Expo Set for Beijing in June 2026
Sustained Worldwide Outreach Drives Greater Collaboration Opportunities BEIJING, Dec. 7, 2025 /PRNewswire/ — The 4th China International Supply Chain Expo (“CISCE,” “the Expo”) will be held in Beijing from June 22 to 26, 2026. To date, more than 300 companies have signed up to exhibit, with preparations moving forward smoothly. Continue Reading Canada-China Forum on… Continue reading The 4th China International Supply Chain Expo Set for Beijing in June 2026
Strutt ev¹ the CES 2026 Best of Innovation Winner Announces Super Early Bird Begins
The awards-winning robotics company officially kicks off its pre-order window ahead of its main launch at CES 2026. SINGAPORE, Dec. 6, 2025 /PRNewswire/ — Strutt, a Singapore-incorporated robotics company advancing smart everyday vehicle, announced the opening of Super Early Bird access for the Strutt ev¹, the only product winning both 2026 CES Best of Innovation… Continue reading Strutt ev¹ the CES 2026 Best of Innovation Winner Announces Super Early Bird Begins